These presentations provide fertile ground for educating patients about infections, self-management options, dealing with uncertainty and responsible use of medicines.

Respiratory inhalers contribute significantly to climate change, principally because the propellant gases in pressurised metered-dose inhalers are potent global warming gases.

Micro-level actions by primary care staff can have a valuable and immediate impact on the healthcare experiences of Aboriginal and Torres Strait Islander people.

As the understanding of post-acute COVID-19 is evolving, regularly updated or ‘living guidelines’ will be crucial for those affected to be provided with best care within the health system.

With an expanding global market of dressing products, selection of wound dressings remains an area of concern.

Peripheral neuropathy, peripheral arterial disease and diabetes-related foot ulcers are the most important risk factors for future amputation.

Noncardiac chest pain is a cause of significant morbidity and can be responsible for a high personal cost and healthcare burden.

Significant morbidity can follow corneal ulceration, with complications including corneal scarring and/or perforation, glaucoma, cataract and loss of vision.

Exposure to domestic and family violence has lifelong impacts on physical health and life expectancy and increases hospitalisation and healthcare usage.

Strangulation has potential significant sequelae such as carotid dissection, hypoxic brain injury and laryngeal injury.

Evidence supports a patient-centred approach to proton pump inhibitor deprescribing involving stepping down the dose before ceasing or switching to pro re nata use.

International travel is resuming, but the COVID-19 pandemic has radically changed the context in terms of regulation, risks and models of travel.

Inflammatory bowel disease, comprising ulcerative colitis and Crohn’s disease, commonly affects individuals of childbearing age.

In late-stage Parkinson’s disease there is a shift to increasing disability from non-motor symptoms unresponsive to levodopa.

Causes of paediatric nasal obstruction are diverse, and differentiating the benign from the worrisome can be challenging because of symptomatic overlap and non-specific clinical presentations.